Global Short Bowel Syndrome Market Growth (Status and Outlook) 2024-2030

September 2024 | 105 pages | ID: G7AB87C65AEDEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Short Bowel Syndrome market size was valued at US$ 434.5 million in 2023. With growing demand in downstream market, the Short Bowel Syndrome is forecast to a readjusted size of US$ 1374.5 million by 2030 with a CAGR of 17.9% during review period.

The research report highlights the growth potential of the global Short Bowel Syndrome market. Short Bowel Syndrome are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Short Bowel Syndrome. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Short Bowel Syndrome market.

Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.

The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.

Key Features:

The report on Short Bowel Syndrome market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Short Bowel Syndrome market. It may include historical data, market segmentation by Type (e.g., GLP-2, Growth Hormone), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Short Bowel Syndrome market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Short Bowel Syndrome market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Short Bowel Syndrome industry. This include advancements in Short Bowel Syndrome technology, Short Bowel Syndrome new entrants, Short Bowel Syndrome new investment, and other innovations that are shaping the future of Short Bowel Syndrome.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Short Bowel Syndrome market. It includes factors influencing customer ' purchasing decisions, preferences for Short Bowel Syndrome product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Short Bowel Syndrome market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Short Bowel Syndrome market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Short Bowel Syndrome market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Short Bowel Syndrome industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Short Bowel Syndrome market.

Market Segmentation:

Short Bowel Syndrome market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • GLP-2
  • Growth Hormone
  • Glutamine
  • Others
Segmentation by application
  • Hospitals
  • Clinics
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Takeda
  • Merck
  • Emmaus Life Sciences
  • Nutrinia
  • GlyPharma Therapeutics
  • OxThera
  • Ardelyx
  • Sancilio & Company
  • Naia Pharmaceuticals
  • Zealand Pharma
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Short Bowel Syndrome Market Size 2019-2030
  2.1.2 Short Bowel Syndrome Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Short Bowel Syndrome Segment by Type
  2.2.1 GLP-2
  2.2.2 Growth Hormone
  2.2.3 Glutamine
  2.2.4 Others
2.3 Short Bowel Syndrome Market Size by Type
  2.3.1 Short Bowel Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
2.4 Short Bowel Syndrome Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
2.5 Short Bowel Syndrome Market Size by Application
  2.5.1 Short Bowel Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Short Bowel Syndrome Market Size Market Share by Application (2019-2024)

3 SHORT BOWEL SYNDROME MARKET SIZE BY PLAYER

3.1 Short Bowel Syndrome Market Size Market Share by Players
  3.1.1 Global Short Bowel Syndrome Revenue by Players (2019-2024)
  3.1.2 Global Short Bowel Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Short Bowel Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SHORT BOWEL SYNDROME BY REGIONS

4.1 Short Bowel Syndrome Market Size by Regions (2019-2024)
4.2 Americas Short Bowel Syndrome Market Size Growth (2019-2024)
4.3 APAC Short Bowel Syndrome Market Size Growth (2019-2024)
4.4 Europe Short Bowel Syndrome Market Size Growth (2019-2024)
4.5 Middle East & Africa Short Bowel Syndrome Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Short Bowel Syndrome Market Size by Country (2019-2024)
5.2 Americas Short Bowel Syndrome Market Size by Type (2019-2024)
5.3 Americas Short Bowel Syndrome Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Short Bowel Syndrome Market Size by Region (2019-2024)
6.2 APAC Short Bowel Syndrome Market Size by Type (2019-2024)
6.3 APAC Short Bowel Syndrome Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Short Bowel Syndrome by Country (2019-2024)
7.2 Europe Short Bowel Syndrome Market Size by Type (2019-2024)
7.3 Europe Short Bowel Syndrome Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Short Bowel Syndrome by Region (2019-2024)
8.2 Middle East & Africa Short Bowel Syndrome Market Size by Type (2019-2024)
8.3 Middle East & Africa Short Bowel Syndrome Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SHORT BOWEL SYNDROME MARKET FORECAST

10.1 Global Short Bowel Syndrome Forecast by Regions (2025-2030)
  10.1.1 Global Short Bowel Syndrome Forecast by Regions (2025-2030)
  10.1.2 Americas Short Bowel Syndrome Forecast
  10.1.3 APAC Short Bowel Syndrome Forecast
  10.1.4 Europe Short Bowel Syndrome Forecast
  10.1.5 Middle East & Africa Short Bowel Syndrome Forecast
10.2 Americas Short Bowel Syndrome Forecast by Country (2025-2030)
  10.2.1 United States Short Bowel Syndrome Market Forecast
  10.2.2 Canada Short Bowel Syndrome Market Forecast
  10.2.3 Mexico Short Bowel Syndrome Market Forecast
  10.2.4 Brazil Short Bowel Syndrome Market Forecast
10.3 APAC Short Bowel Syndrome Forecast by Region (2025-2030)
  10.3.1 China Short Bowel Syndrome Market Forecast
  10.3.2 Japan Short Bowel Syndrome Market Forecast
  10.3.3 Korea Short Bowel Syndrome Market Forecast
  10.3.4 Southeast Asia Short Bowel Syndrome Market Forecast
  10.3.5 India Short Bowel Syndrome Market Forecast
  10.3.6 Australia Short Bowel Syndrome Market Forecast
10.4 Europe Short Bowel Syndrome Forecast by Country (2025-2030)
  10.4.1 Germany Short Bowel Syndrome Market Forecast
  10.4.2 France Short Bowel Syndrome Market Forecast
  10.4.3 UK Short Bowel Syndrome Market Forecast
  10.4.4 Italy Short Bowel Syndrome Market Forecast
  10.4.5 Russia Short Bowel Syndrome Market Forecast
10.5 Middle East & Africa Short Bowel Syndrome Forecast by Region (2025-2030)
  10.5.1 Egypt Short Bowel Syndrome Market Forecast
  10.5.2 South Africa Short Bowel Syndrome Market Forecast
  10.5.3 Israel Short Bowel Syndrome Market Forecast
  10.5.4 Turkey Short Bowel Syndrome Market Forecast
  10.5.5 GCC Countries Short Bowel Syndrome Market Forecast
10.6 Global Short Bowel Syndrome Forecast by Type (2025-2030)
10.7 Global Short Bowel Syndrome Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Takeda
  11.1.1 Takeda Company Information
  11.1.2 Takeda Short Bowel Syndrome Product Offered
  11.1.3 Takeda Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Takeda Main Business Overview
  11.1.5 Takeda Latest Developments
11.2 Merck
  11.2.1 Merck Company Information
  11.2.2 Merck Short Bowel Syndrome Product Offered
  11.2.3 Merck Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Merck Main Business Overview
  11.2.5 Merck Latest Developments
11.3 Emmaus Life Sciences
  11.3.1 Emmaus Life Sciences Company Information
  11.3.2 Emmaus Life Sciences Short Bowel Syndrome Product Offered
  11.3.3 Emmaus Life Sciences Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Emmaus Life Sciences Main Business Overview
  11.3.5 Emmaus Life Sciences Latest Developments
11.4 Nutrinia
  11.4.1 Nutrinia Company Information
  11.4.2 Nutrinia Short Bowel Syndrome Product Offered
  11.4.3 Nutrinia Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Nutrinia Main Business Overview
  11.4.5 Nutrinia Latest Developments
11.5 GlyPharma Therapeutics
  11.5.1 GlyPharma Therapeutics Company Information
  11.5.2 GlyPharma Therapeutics Short Bowel Syndrome Product Offered
  11.5.3 GlyPharma Therapeutics Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 GlyPharma Therapeutics Main Business Overview
  11.5.5 GlyPharma Therapeutics Latest Developments
11.6 OxThera
  11.6.1 OxThera Company Information
  11.6.2 OxThera Short Bowel Syndrome Product Offered
  11.6.3 OxThera Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 OxThera Main Business Overview
  11.6.5 OxThera Latest Developments
11.7 Ardelyx
  11.7.1 Ardelyx Company Information
  11.7.2 Ardelyx Short Bowel Syndrome Product Offered
  11.7.3 Ardelyx Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Ardelyx Main Business Overview
  11.7.5 Ardelyx Latest Developments
11.8 Sancilio & Company
  11.8.1 Sancilio & Company Company Information
  11.8.2 Sancilio & Company Short Bowel Syndrome Product Offered
  11.8.3 Sancilio & Company Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Sancilio & Company Main Business Overview
  11.8.5 Sancilio & Company Latest Developments
11.9 Naia Pharmaceuticals
  11.9.1 Naia Pharmaceuticals Company Information
  11.9.2 Naia Pharmaceuticals Short Bowel Syndrome Product Offered
  11.9.3 Naia Pharmaceuticals Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Naia Pharmaceuticals Main Business Overview
  11.9.5 Naia Pharmaceuticals Latest Developments
11.10 Zealand Pharma
  11.10.1 Zealand Pharma Company Information
  11.10.2 Zealand Pharma Short Bowel Syndrome Product Offered
  11.10.3 Zealand Pharma Short Bowel Syndrome Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Zealand Pharma Main Business Overview
  11.10.5 Zealand Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Short Bowel Syndrome Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of GLP-2
Table 3. Major Players of Growth Hormone
Table 4. Major Players of Glutamine
Table 5. Major Players of Others
Table 6. Short Bowel Syndrome Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Short Bowel Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
Table 9. Short Bowel Syndrome Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Short Bowel Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Short Bowel Syndrome Market Size Market Share by Application (2019-2024)
Table 12. Global Short Bowel Syndrome Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Short Bowel Syndrome Revenue Market Share by Player (2019-2024)
Table 14. Short Bowel Syndrome Key Players Head office and Products Offered
Table 15. Short Bowel Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Short Bowel Syndrome Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Short Bowel Syndrome Market Size Market Share by Regions (2019-2024)
Table 20. Global Short Bowel Syndrome Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Short Bowel Syndrome Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Short Bowel Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Short Bowel Syndrome Market Size Market Share by Country (2019-2024)
Table 24. Americas Short Bowel Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
Table 26. Americas Short Bowel Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Short Bowel Syndrome Market Size Market Share by Application (2019-2024)
Table 28. APAC Short Bowel Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Short Bowel Syndrome Market Size Market Share by Region (2019-2024)
Table 30. APAC Short Bowel Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
Table 32. APAC Short Bowel Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Short Bowel Syndrome Market Size Market Share by Application (2019-2024)
Table 34. Europe Short Bowel Syndrome Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Short Bowel Syndrome Market Size Market Share by Country (2019-2024)
Table 36. Europe Short Bowel Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
Table 38. Europe Short Bowel Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Short Bowel Syndrome Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Short Bowel Syndrome Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Short Bowel Syndrome Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Short Bowel Syndrome Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Short Bowel Syndrome
Table 47. Key Market Challenges & Risks of Short Bowel Syndrome
Table 48. Key Industry Trends of Short Bowel Syndrome
Table 49. Global Short Bowel Syndrome Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Short Bowel Syndrome Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Short Bowel Syndrome Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Short Bowel Syndrome Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Takeda Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 54. Takeda Short Bowel Syndrome Product Offered
Table 55. Takeda Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Takeda Main Business
Table 57. Takeda Latest Developments
Table 58. Merck Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 59. Merck Short Bowel Syndrome Product Offered
Table 60. Merck Main Business
Table 61. Merck Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Merck Latest Developments
Table 63. Emmaus Life Sciences Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 64. Emmaus Life Sciences Short Bowel Syndrome Product Offered
Table 65. Emmaus Life Sciences Main Business
Table 66. Emmaus Life Sciences Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Emmaus Life Sciences Latest Developments
Table 68. Nutrinia Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 69. Nutrinia Short Bowel Syndrome Product Offered
Table 70. Nutrinia Main Business
Table 71. Nutrinia Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Nutrinia Latest Developments
Table 73. GlyPharma Therapeutics Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 74. GlyPharma Therapeutics Short Bowel Syndrome Product Offered
Table 75. GlyPharma Therapeutics Main Business
Table 76. GlyPharma Therapeutics Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GlyPharma Therapeutics Latest Developments
Table 78. OxThera Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 79. OxThera Short Bowel Syndrome Product Offered
Table 80. OxThera Main Business
Table 81. OxThera Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. OxThera Latest Developments
Table 83. Ardelyx Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 84. Ardelyx Short Bowel Syndrome Product Offered
Table 85. Ardelyx Main Business
Table 86. Ardelyx Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Ardelyx Latest Developments
Table 88. Sancilio & Company Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 89. Sancilio & Company Short Bowel Syndrome Product Offered
Table 90. Sancilio & Company Main Business
Table 91. Sancilio & Company Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Sancilio & Company Latest Developments
Table 93. Naia Pharmaceuticals Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 94. Naia Pharmaceuticals Short Bowel Syndrome Product Offered
Table 95. Naia Pharmaceuticals Main Business
Table 96. Naia Pharmaceuticals Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Naia Pharmaceuticals Latest Developments
Table 98. Zealand Pharma Details, Company Type, Short Bowel Syndrome Area Served and Its Competitors
Table 99. Zealand Pharma Short Bowel Syndrome Product Offered
Table 100. Zealand Pharma Main Business
Table 101. Zealand Pharma Short Bowel Syndrome Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Zealand Pharma Latest Developments

LIST OF FIGURES

Figure 1. Short Bowel Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Short Bowel Syndrome Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Short Bowel Syndrome Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Short Bowel Syndrome Sales Market Share by Country/Region (2023)
Figure 8. Short Bowel Syndrome Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Short Bowel Syndrome Market Size Market Share by Type in 2023
Figure 10. Short Bowel Syndrome in Hospitals
Figure 11. Global Short Bowel Syndrome Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Short Bowel Syndrome in Clinics
Figure 13. Global Short Bowel Syndrome Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Global Short Bowel Syndrome Market Size Market Share by Application in 2023
Figure 15. Global Short Bowel Syndrome Revenue Market Share by Player in 2023
Figure 16. Global Short Bowel Syndrome Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Short Bowel Syndrome Market Size 2019-2024 ($ Millions)
Figure 18. APAC Short Bowel Syndrome Market Size 2019-2024 ($ Millions)
Figure 19. Europe Short Bowel Syndrome Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Short Bowel Syndrome Market Size 2019-2024 ($ Millions)
Figure 21. Americas Short Bowel Syndrome Value Market Share by Country in 2023
Figure 22. United States Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Short Bowel Syndrome Market Size Market Share by Region in 2023
Figure 27. APAC Short Bowel Syndrome Market Size Market Share by Type in 2023
Figure 28. APAC Short Bowel Syndrome Market Size Market Share by Application in 2023
Figure 29. China Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Short Bowel Syndrome Market Size Market Share by Country in 2023
Figure 36. Europe Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
Figure 37. Europe Short Bowel Syndrome Market Size Market Share by Application (2019-2024)
Figure 38. Germany Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Short Bowel Syndrome Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Short Bowel Syndrome Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 52. APAC Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 53. Europe Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 55. United States Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 56. Canada Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 59. China Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 60. Japan Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 61. Korea Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 63. India Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 64. Australia Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 65. Germany Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 66. France Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 67. UK Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 68. Italy Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 69. Russia Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 70. Spain Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 73. Israel Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Short Bowel Syndrome Market Size 2025-2030 ($ Millions)
Figure 76. Global Short Bowel Syndrome Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Short Bowel Syndrome Market Size Market Share Forecast by Application (2025-2030)